The Etro Studies

Patient-centric. Science-focused.

Explore the Phase III clinical development program for Ulcerative Colitis (UC) and Crohn’s disease

The efficacy and safety of Etrolizumab in UC and Crohn’s disease will be examined in 6 pivotal Phase III trials in over 3700 patients, including head-to-head studies versus anti-TNFs.

Etro Studies clinical trials related to UC in the US include:

  • Hibiscus I & II
  • Laurel
  • Hickory
  • Cottonwood

Review the details of this study now »

Etro Studies clinical trials related to Crohn’s include:

  • Bergamot
  • Juniper

Review the details of this study now »

Etro Studies clinical trials related to UC available outside of the US include:

  • Gardenia

Review the details of this study now »

 

  • Print
  •  © 2019 All Rights Reserved. This site is intended for U.S. healthcare professionals only.

Etrolizumab is still being tested and has not been approved by any regulatory authorities, including the U.S. Food and Drug Administration (FDA).
It is currently only available through clinical trials. The safety and effectiveness of etrolizumab are currently not known.

Notice

×

The information contained in this section of the site is intended for U.S. healthcare professionals only. Please select OK if you are a U.S. healthcare professional.

Cancel OK